Shares in Sequenom dropped 9.2 percent for the five-day trading week ended Tuesday to lead all decliners in the BCW Index. It was the second week in a row that Sequenom’s shares lost value, though there has been no recent news regarding the firm. Sequenom filed a prospectus earlier this year for the possible sale of common shares.
Bruker BioSciences led gainers for the week with a 5 percent jump in its stock. Bruker’s stock has been trading near its 52-week high of $11.36.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.